Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ 5,164,429	$ (322,270)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
General and administrative expenses paid by Sponsor through note payable		24,589
Change in fair value of derivative warrant liabilities	(6,077,450)	(452,450)
Financing cost - derivative warrant liabilities		314,650
Gain on investments held in Trust Account	(183,623)	(35,907)
Changes in operating assets and liabilities:
Prepaid expenses	91,209	(184,299)
Accounts payable	227,405	25,294
Franchise tax payable	(95,979)	217,534
Accrued expenses	(89,000)	13,000
Net cash used in operating activities	(963,009)	(399,859)
Cash Flows from Investing Activities
Cash deposited in Trust Account for extension	(76,041)
Withdrawal of interest from Trust Account to pay for franchise taxes	188,451
Cash deposited in Trust Account		(116,725,000)
Net cash used in investing activities	112,410	(116,725,000)
Cash Flows from Financing Activities:
Proceeds from note payable	250,000
Repayment of note payable to Sponsor		(108,226)
Proceeds received from initial public offering, gross		115,000,000
Proceeds received from private placement		5,525,000
Offering costs paid		(2,584,078)
Net cash provided by financing activities	250,000	117,832,696
Net (decrease) increase in cash	(600,599)	707,837
Cash - beginning of the period	707,837
Cash - end of the period	107,238	707,837
Supplemental disclosure of noncash activities:
Deemed dividend to Class A common stock being redeemed	41,058
Offering costs included in accrued expenses		75,000
Offering costs paid through note payable to Sponsor		77,370
Deferred underwriting commissions in connection with the initial public offering		4,025,000
Accretion of Class A common stock to redemption amount		$ 13,383,298